{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:32:45Z","timestamp":1787315565734,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-0601"],"award-info":[{"award-number":["IIRP-2023-0601"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metastatic dissemination is driven by rare Circulating Tumour Cells (CTCs) that exhibit pronounced phenotypic plasticity and dynamic interactions with different components in the bloodstream. In Oral Squamous Cell Carcinoma (OSCC), limited resolution of epithelial, mesenchymal, and platelet-associated CTC-states has constrained biological understanding of early tumour spread and hindered translational interpretation. In this study, we identify, count and characterize distinct epithelial, mesenchymal, and platelet-associated CTC-states in a cohort of 33 patients using a strategic workflow involving hematopoietic cell depletion with multiparametric flow-cytometric analysis. The FACS (Fluorescence-assisted cell sorting)-strategy incorporated epithelial tumour-associated markers (EpCAM, EGFR, and Cytokeratin), mesenchymal markers (VIM and N-Cadherin), and platelet\/leukocyte markers (CD41 and CD45) to resolve biologically distinct CTC-subpopulations. Analytical robustness was established through spike-in experiments using OSCC cell line i.e., Cal27, demonstrating linear detection across clinically relevant ranges(1-100cells\/mL of blood, Spearman\u2019s\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.8738,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) and sensitive recovery of rare tumour cells with a Limit of Detection of 1 cell\/mL, Limit of Quantification of 10 cells\/mL, and Limit of Blank of 1.779 cells\/mL. Molecular validation of sorted populations using whole transcriptome amplification-quantitative PCR confirmed tumour-associated marker expression and absence of hematopoietic contamination. Application of this approach in OSCC patients revealed detectable CTCs in 70% of the cases (ranging from 14.20 to 340.5 CTCs-related events\/mL). Importantly, CTCs were identified across discrete phenotypic states, including platelet-associated CTC-clusters that were not captured by epithelial marker-restricted strategies. Quantitative comparison of CTC subtype proportions revealed majority (nearly 83%) of CTCs present as platelet clusters, followed by Epithelial-Single CTCs (21.21%). In comparison, CTCs with only mesenchymal phenotype constitute only 3.22% of the total CTC-population. Receiver operating characteristic analysis supported the discriminatory capacity of CTC enumeration and enabled the definition of a biologically relevant threshold of &gt;\u200919.40 events mL for CTC positivity. Taken together, our findings outline a practical workflow for identifying and quantifying different CTC-states in OSCC, with platelet-associated CTCs emerging as the predominant population detected. These findings support the importance of incorporating phenotypic heterogeneity and platelet-associated tumour cell interactions into future liquid biopsy-based translational pathology research and clinical biomarker development in OSCC.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-57427-z","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:41:22Z","timestamp":1781044882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of epithelial, mesenchymal, and platelet-associated circulating tumour cells with translational implications in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4810-3290","authenticated-orcid":false,"given":"Geeta S.","family":"Boora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1016-5920","authenticated-orcid":false,"given":"Anshika","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijuneeta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-7620","authenticated-orcid":false,"given":"Jaimanti","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-7838","authenticated-orcid":false,"given":"Sushmita","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-3118","authenticated-orcid":false,"given":"Arnab","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"57427_CR1","first-page":"1","volume":"132","author":"ME Menezes","year":"2016","unstructured":"Menezes, M. E. et al. Detecting Tumour Metastases: The Road to Therapy Starts Here. Adv. Cancer Res. 132, 1\u201344 (2016).","journal-title":"Adv. Cancer Res."},{"key":"57427_CR2","doi-asserted-by":"crossref","unstructured":"Pantel, K. & Alix-Panabi\u00e8res, C. Crucial roles of circulating tumour cells in the metastatic cascade and tumour immune escape: biology and clinical translation. J. Immunother Cancer ;10(12) (2022).","DOI":"10.1136\/jitc-2022-005615"},{"issue":"10","key":"57427_CR3","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/2159-8290.CD-25-0164","volume":"15","author":"C Alix-Panabi\u00e8res","year":"2025","unstructured":"Alix-Panabi\u00e8res, C. & Pantel, K. From Discovery to Diagnosis: A Perspective for Circulating Tumour Cells in Personalized Oncology. Cancer Discov. 15 (10), 1985\u20132001 (2025).","journal-title":"Cancer Discov"},{"key":"57427_CR4","doi-asserted-by":"publisher","first-page":"1002321","DOI":"10.37349\/etat.2025.1002321","volume":"6","author":"Z Myrkhiyeva","year":"2025","unstructured":"Myrkhiyeva, Z. et al. Circulating tumour cells: overcoming challenges of detecting a needle in a haystack. Explor. Target. Antitumour Ther. 6, 1002321 (2025).","journal-title":"Explor. Target. Antitumour Ther."},{"issue":"1","key":"57427_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","volume":"9","author":"X Gu","year":"2024","unstructured":"Gu, X., Wei, S. & Lv, X. Circulating tumour cells: from new biological insights to clinical practice. Signal. Transduct. Target. Ther. 9 (1), 226 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"57427_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Homophilic CD44 Interactions Mediate Tumour Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov. 9 (1), 96\u2013113 (2019).","journal-title":"Cancer Discov"},{"issue":"7745","key":"57427_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566 (7745), 553\u2013557 (2019).","journal-title":"Nature"},{"issue":"5","key":"57427_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle, M., Begum, S. & Hynes, R. O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 20 (5), 576\u2013590 (2011).","journal-title":"Cancer Cell."},{"issue":"18","key":"57427_CR9","doi-asserted-by":"publisher","first-page":"e193521","DOI":"10.1172\/JCI193521","volume":"135","author":"D Scholten","year":"2025","unstructured":"Scholten, D. et al. Double-positive T cells form heterotypic clusters with circulating tumour cells to foster cancer metastasis. J. Clin. Invest. 135 (18), e193521 (2025).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"57427_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.62347\/JAYK5667","volume":"15","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. Advances and potentials in platelet-circulating tumour cell crosstalk. Am. J. Cancer Res. 15 (2), 407\u2013425 (2025).","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"57427_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-025-03877-w","volume":"25","author":"J Gan","year":"2025","unstructured":"Gan, J., Zhang, X. & Guo, J. The role of platelets in tumour immune evasion and metastasis: mechanisms and therapeutic implications. Cancer Cell. Int. 25 (1), 258 (2025).","journal-title":"Cancer Cell. Int."},{"key":"57427_CR12","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.oraloncology.2021.105636","volume":"124","author":"A Chauhan","year":"2022","unstructured":"Chauhan, A., Kaur, R., Ghoshal, S., Chatterjee, D. & Pal, A. Potential prognostic and predictive role of baseline circulating tumour cells in head and neck squamous cell carcinoma. Oral Oncol. 124, 105636 (2022).","journal-title":"Oral Oncol."},{"key":"57427_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bios.2017.11.026","volume":"102","author":"N Sun","year":"2018","unstructured":"Sun, N., Li, X., Wang, Z., Li, Y. & Pei, R. High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumour cells (ISET) method. Biosens. Bioelectron. 102, 157\u2013163 (2018).","journal-title":"Biosens. Bioelectron."},{"key":"57427_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.01.002","volume":"125","author":"SJ Hao","year":"2018","unstructured":"Hao, S. J., Wan, Y., Xia, Y. Q., Zou, X. & Zheng, S. Y. Size-based separation methods of circulating tumour cells. Adv. Drug Deliv Rev. 125, 3\u201320 (2018).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"3","key":"57427_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","volume":"13","author":"S Riethdorf","year":"2007","unstructured":"Riethdorf, S. et al. Detection of circulating tumour cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 13 (3), 920\u2013928 (2007).","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"57427_CR16","doi-asserted-by":"publisher","first-page":"24677","DOI":"10.18632\/oncotarget.8250","volume":"7","author":"KA Hyun","year":"2016","unstructured":"Hyun, K. A. et al. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumour cells from metastatic breast cancer. Oncotarget 7 (17), 24677\u201324687 (2016).","journal-title":"Oncotarget"},{"key":"57427_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.33393\/jcb.2023.2629","volume":"12","author":"A Templeman","year":"2023","unstructured":"Templeman, A. et al. Analytical performance of the FDA-cleared Parsortix\u00ae PC1 system. J. Circ. Biomark. 12, 26\u201333 (2023).","journal-title":"J. Circ. Biomark."},{"key":"57427_CR18","doi-asserted-by":"publisher","first-page":"1269211","DOI":"10.3389\/fonc.2024.1269211","volume":"14","author":"A Chauhan","year":"2024","unstructured":"Chauhan, A. et al. A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma. Front. Oncol. 14, 1269211 (2024).","journal-title":"Front. Oncol."},{"key":"57427_CR19","doi-asserted-by":"crossref","unstructured":"Chazotte, B. Labeling nuclear DNA with hoechst 33342. Cold Spring Harb Protoc. ;2011(1): (2011). pdb.prot5557","DOI":"10.1101\/pdb.prot5557"},{"issue":"Suppl 1(Suppl 1","key":"57427_CR20","first-page":"S49","volume":"29","author":"DA Armbruster","year":"2008","unstructured":"Armbruster, D. A. & Pry, T. Limit of blank, Limit of detection and Limit of quantitation. Clin. Biochem. Rev. 29 (Suppl 1(Suppl 1), S49\u2013S52 (2008).","journal-title":"Clin. Biochem. Rev."},{"issue":"3","key":"57427_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2013.03.004","volume":"23","author":"JP Thiery","year":"2013","unstructured":"Thiery, J. P. & Lim, C. T. Tumour dissemination: an EMT affair. Cancer Cell. 23 (3), 272\u2013273 (2013).","journal-title":"Cancer Cell."},{"issue":"8","key":"57427_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1158\/1541-7786.MCR-10-0490","volume":"9","author":"AJ Armstrong","year":"2011","unstructured":"Armstrong, A. J. et al. Circulating tumour cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9 (8), 997\u20131007 (2011).","journal-title":"Mol. Cancer Res."},{"key":"57427_CR23","unstructured":"ThermoFisher, S. Technical Reference Library. https:\/\/www.thermofisher.com\/in\/en\/home\/references\/newsletters-and-journals\/bioprobes-journal-of-cell-biology-applications\/bioprobes-issues-2010\/bioprobes-62\/optimal-pairing-of-dyes-and-antibodies-for-flow-cytometry.html#:~:text=Matching%20Dyes%20to%20Appropriate%20Markers,distinguish%20positive%20and%20negative%20populations (Accessed November 2024)."},{"issue":"1","key":"57427_CR24","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1038\/s41467-023-38009-3","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Single-cell metabolic fingerprints discover a cluster of circulating tumour cells with distinct metastatic potential. Nat. Commun. 14 (1), 2485 (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"57427_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12943-025-02465-w","volume":"24","author":"X Ren","year":"2025","unstructured":"Ren, X., Song, M., Liu, X. & He, W. Circulating tumour cells: mechanisms and clinical significance in colorectal cancer metastasis. Mol. Cancer. 24 (1), 242 (2025). Published 2025 Oct 3.","journal-title":"Mol. Cancer"},{"key":"57427_CR26","doi-asserted-by":"publisher","first-page":"1612181","DOI":"10.3389\/pore.2025.1612181","volume":"31","author":"TR Linkner","year":"2025","unstructured":"Linkner, T. R. et al. Circulating tumour cells: indicators of cancer progression, plasticity and utility for therapies. Pathol. Oncol. Res. 31, 1612181 (2025). Published 2025 Oct 20.","journal-title":"Pathol. Oncol. Res."},{"issue":"17","key":"57427_CR27","doi-asserted-by":"publisher","first-page":"24677","DOI":"10.18632\/oncotarget.8250","volume":"7","author":"KA Hyun","year":"2016","unstructured":"Hyun, K. A. et al. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumour cells from metastatic breast cancer. Oncotarget 7 (17), 24677\u201324687 (2016).","journal-title":"Oncotarget"},{"issue":"42","key":"57427_CR28","doi-asserted-by":"publisher","first-page":"44623","DOI":"10.18632\/oncotarget.5977","volume":"6","author":"A Ring","year":"2015","unstructured":"Ring, A. et al. EpCAM based capture detects and recovers circulating tumour cells from all subtypes of breast cancer except claudin-low. Oncotarget 6 (42), 44623\u201344634 (2015).","journal-title":"Oncotarget"},{"key":"57427_CR29","doi-asserted-by":"publisher","first-page":"42612","DOI":"10.1038\/srep42612","volume":"7","author":"J Jiang","year":"2017","unstructured":"Jiang, J. et al. An integrated microfluidic device for rapid and high-sensitivity analysis of circulating tumour cells. Sci. Rep. 7, 42612 (2017). Published 2017 Feb 15.","journal-title":"Sci. Rep."},{"issue":"50","key":"57427_CR30","doi-asserted-by":"publisher","first-page":"87710","DOI":"10.18632\/oncotarget.21197","volume":"8","author":"Y Maertens","year":"2017","unstructured":"Maertens, Y. et al. Comparison of isolation platforms for detection of circulating renal cell carcinoma cells. Oncotarget 8 (50), 87710\u201387717 (2017).","journal-title":"Oncotarget"},{"issue":"7702","key":"57427_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556 (7702), 463\u2013468 (2018).","journal-title":"Nature"},{"issue":"2","key":"57427_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/ol.2024.14846","volume":"29","author":"H Li","year":"2024","unstructured":"Li, H., Li, P., Li, F. & Wang, T. Application of CellSearch technique in detection of peripheral blood circulating tumour cell count in patients with head and neck cancer and its association with prognosis. Oncol. Lett. 29 (2), 100 (2024).","journal-title":"Oncol. Lett."},{"issue":"21","key":"57427_CR33","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.3390\/cancers13215519","volume":"13","author":"K Payne","year":"2021","unstructured":"Payne, K. et al. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardized Approach to Microfluidic CTC Biomarker Discovery. Cancers (Basel). 13 (21), 5519 (2021).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"57427_CR34","doi-asserted-by":"publisher","first-page":"109547","DOI":"10.1016\/j.isci.2024.109547","volume":"27","author":"W Zhou","year":"2024","unstructured":"Zhou, W. et al. Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis. iScience 27 (5), 109547 (2024).","journal-title":"iScience"},{"issue":"1","key":"57427_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-025-03877-w","volume":"25","author":"J Gan","year":"2025","unstructured":"Gan, J., Zhang, X. & Guo, J. The role of platelets in tumour immune evasion and metastasis: mechanisms and therapeutic implications. Cancer Cell. Int. 25 (1), 258 (2025).","journal-title":"Cancer Cell. Int."},{"key":"57427_CR36","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.critrevonc.2021.103502","volume":"167","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Zhang, Y., Ding, Y. & Zhuang, R. Platelet-mediated tumour metastasis mechanism and the role of cell adhesion molecules. Crit. Rev. Oncol. Hematol. 167, 103502 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57427-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:47Z","timestamp":1787313767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57427-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57427-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the Institutional Ethics Committee of PGIMER, Chandigarh (Approval no. IEC-07\/2022\u20132510) and with the 1964 Declaration of Helsinki and its later amendments. Informed written consent was obtained from all participants prior to sample collection.","order":2,"name":"Ethics","label":"Ethical consideration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26281"}}